|
 |
|
|
| |
Murdoch University, Info Kinetics sign MoU
 |
|
| Australia's Murdoch University has signed a MoU with Malaysian clinical research organization Info Kinetics to deliver accredited drug analysis services to Western Australian organizations |
|
 |
|
|
| |
|
|
| |
|
|
| |
| GSK to market Daiichi Sankyo drugs in India
|
|
| Japan's second largest pharma company Daiichi Sankyo has tied up with Glaxo Smith Kline Pharmaceuticals Limited in India to sell its anti-hypertension drug and combination products in India |
|
|
|
|
| |
|
|
| |
| Lifestyle changes helping Indian pharma growth
|
|
| Lifestyle changes in India is fuelling the growth of Indian pharma sector and if indications are right, the industry, already growing faster than the world average, might double its business in just five years |
|
|
|
|
| |
| BMS, KAI to develop cardiovascular disease drugs
|
|
| BMS and KAI Pharmaceuticals have announced an exclusive agreement for the global development and commercialization of KAI-9803, KAIs proprietary, first-in-class inhibitor of the delta protein |
|
|
|
|
| |
|
|
| |
|
|
| More |
